Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Jan. 28, 2017	Jan. 30, 2016
Cash flows from operating activities:
Net income	$ 217,129	$ 164,504
Adjustments to reconcile net income to net cash provided by operations:
Depreciation	34,379	33,209
Amortization of intangibles	19,947	18,347
Stock-based compensation expense	16,529	15,609
Loss on extinguishment of debt	0	3,290
Excess tax benefit-stock options	(8,102)	(986)
Deferred income taxes	(7,055)	(7,717)
Other non-cash activity	13,071	744
Changes in operating assets and liabilities	28,594	(7,295)
Total adjustments	97,363	55,201
Net cash provided by operating activities	314,492	219,705
Cash flows from investing activities:
Purchases of short-term available-for-sale investments	(326,908)	(1,632,014)
Maturities of short-term available-for-sale investments	1,844,380	1,409,538
Sales of short-term available-for-sale investments	287,601	47,950
Additions to property, plant and equipment	(28,337)	(23,128)
Payments for acquisitions, net of cash acquired	(1,036)	0
Changes in other assets	(5,946)	(6,711)
Net cash provided by (used for) investing activities	1,769,754	(204,365)
Cash flows from financing activities:
Early termination of debt	0	(378,156)
Payments of derivative instruments	0	(33,430)
Proceeds from debt	2,072,306	1,235,331
Payments of deferred financing fees	(5,625)	0
Proceeds from derivative instruments	3,904	0
Dividend payments to shareholders	(129,683)	(124,658)
Repurchase of common stock	(3,106)	(131,977)
Proceeds from employee stock plans	34,432	6,229
Changes in other financing activities	2,221	(2,544)
Excess tax benefit-stock options	8,102	986
Net cash provided by financing activities	1,982,551	571,781
Effect of exchange rate changes on cash	(666)	(1,032)
Net increase in cash and cash equivalents	4,066,131	586,089
Cash and cash equivalents at beginning of period	921,132	884,353
Cash and cash equivalents at end of period	$ 4,987,263	$ 1,470,442